Publications – EUNETHYDIS

Santosh P., Cortese S., Hollis C., Bölte S., Daley D., Coghill D., Holtmann M., Sonuga-Barke E. J. S., Buitelaar J., Banaschewski T., Stringaris A., Döpfner M., Van der Oord S., Carucci S., Brandeis D., Nagy P., Ferrin M., Baeyens D., van den Hoofdakker B. J., Purper-Ouakil D., Ramos-Quiroga A., Romanos M., Soutullo C. A., Thapar A., Wong I. C. K., Zuddas A., Galera C., Simonoff E. (2023). Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic. European Child & Adolescent Psychiatry 2023, February 11, 2023, DOI: https://doi.org/10.1007/s00787-023-02148-1.

Westwood S.J., Parlatini V., Rubia K., Cortese S., Sonuga-Barke E.J.S., European ADHD Guidelines Group (EAGG) (2023). Computerized cognitive training in attention-deficit/hyperactivity disorder (ADHD): a meta-analysis of randomized controlled trials with blinded and objective outcomes. Mol Psychiatry 2023, Published Online March 29, 2023, DOI: https://doi.org/10.1038/s41380-023-02000-7

Coghill, D., Banaschewski, T., Cortese, S., Asherson P., Brandeis D., Buitelaar J., Daley D., Danckaerts M., Dittmann R.W., Doepfner M., Ferrin M., Hollis C., Holtmann M., Paramala S., Sonuga-Barke E., Soutullo C., Steinhausen H-C., Van der Oord S., Wong I.C.K., Zuddas A., Simonoff E. (2021). The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG). Eur Child Adolesc Psychiatry 2021, Published Online October 22, 2021, DOI: https://doi.org/10.1007/s00787-021-01871-x.

Cortese S., Coghill D., Santosh P., Hollis C., Simonoff E., European ADHD Guidelines Group (2020). Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group. Lancet Child Adolesc Health 2020, Published Online May 12, 2020, DOI: https://doi.org/10.1016/S2352-4642(20)30144-9.

Cortese S., Asherson P., Sonuga-Barke E., Banaschewski T., Brandeis D., Buitelaar J., Coghill D., Daley D., Danckaerts M., Dittmann RW., Doepfner M., Ferrin M., Hollis C., Holtmann M., Konofal E., Lecendreux M., Santosh P., Rothenberger A., Soutullo C., Steinhausen HC., Taylor E., Van der Oord S., Wong I., Zuddas A., Simonoff E., for the European ADHD Guidelines Group (2019). ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group. Lancet Child Adolesc Health 2020, Published Online April 17, 2020, DOI: https://doi.org/10.1016/S2352-4642(20)30110-3.

Wong ICK, Banaschewski T, Buitelaar J, Cortese S, Döpfner M, Simonoff E, Coghill D; European ADHD Guidelines Group. (2019). Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trials. Lancet Psychiatry. 2019;6(6):528‐537. doi:10.1016/S2215-0366(19)30096-3. PubMed PMID: 31122482.

Cipriani A, Adamo N, Giovane CD, Coghill D, Banaschewski T, Hollis C, Zuddas A, Simonoff E, Cortese S (2018). Unbalanced risk-benefit analysis of ADHD drugs – Authors’ reply. Lancet Psychiatry. 2018;5(11):871‐873. doi:10.1016/S2215-0366(18)30396-1. PubMed PMID: 30401441.

Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727‐738. doi:10.1016/S2215-0366(18)30269-4. PubMed PMID: 30097390; PubMed Central PMCID: PMC6109107.

Cortese S, Adamo N, Mohr-Jensen C, Hayes AJ, Bhatti S, Carucci S, Del Giovane C, Atkinson LZ, Banaschewski T, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A, Coghill D; European ADHD Guidelines Group (EAGG). (2017). Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis. BMJ Open. 2017 Jan 10;7(1):e013967. doi: 10.1136/bmjopen-2016-013967. PubMed PMID: 28073796; PubMed Central PMCID: PMC5253538.

Daley D., Van der Oord S., Ferrin M., Cortese S., Danckaerts M., Doepfner M., et al. (2017). Practitioner review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with ADHD. Journal of Child Psychology and Psychiatry, 59: 932-947.

Banaschewski T., Buitelaar J., Chui C.S.L., Coghill D., Cortese S., Simonoff E., et al. (2016). Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater. Evidence Based Mental Health, 19: 97-99.

Cortese S, Brandeis D, Holtmann M, Sonuga-Barke EJ; European ADHD Guidelines Group (EAGG). (2016). The European ADHD Guidelines Group replies. J Am Acad Child Adolesc Psychiatry. 2016 Dec;55(12):1092-1093. doi: 10.1016/j.jaac.2016.09.492. PubMed PMID: 27871646.

Cortese S, Ferrin M, Brandeis D, Holtmann M, Aggensteiner P, Daley D, Santosh P, Simonoff E, Stevenson J, Stringaris A, Sonuga-Barke EJ; European ADHD Guidelines Group (EAGG). (2016). Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials. J Am Acad Child Adolesc Psychiatry. 2016 Jun;55(6):444-55. doi: 10.1016/j.jaac.2016.03.007. Epub 2016 Apr 1. Review. PubMed PMID: 27238063.

Cortese S, Ferrin M, Brandeis D, Buitelaar J, Daley D, Dittmann RW, Holtmann M, Santosh P, Stevenson J, Stringaris A, Zuddas A, Sonuga-Barke EJ; European ADHD Guidelines Group (EAGG). (2015). Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. J Am Acad Child Adolesc Psychiatry. 2015 Mar;54(3):164-74. doi: 10.1016/j.jaac.2014.12.010. Epub 2014 Dec 29. Review. Erratum in: J Am Acad Child Adolesc Psychiatry. 2015 May;54(5):433. PubMed PMID: 25721181; PubMed Central PMCID: PMC4382075.

Daley D, van der Oord S, Ferrin M, Danckaerts M, Doepfner M, Cortese S, Sonuga-Barke EJ; European ADHD Guidelines Group. (2014). Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):835-47, 847.e1-5. doi: 10.1016/j.jaac.2014.05.013. Epub 2014 Jun 26. Review. PubMed PMID: 25062591.

Stevenson J, Buitelaar J, Cortese S, Ferrin M, Konofal E, Lecendreux M, Simonoff E, Wong IC, Sonuga-Barke E. (2014). Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder–an appraisal of the evidence on efficacy and recommendations on the design of future studies J Child Psychol Psychiatry. 2014 May;55(5):416-27. doi: 10.1111/jcpp.12215. Epub 2014 Feb 19. Review. PubMed PMID: 24552603

Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J; European ADHD Guidelines Group. (2013). Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents J Child Psychol Psychiatry. 2013 Mar;54(3):227-46. doi: 10.1111/jcpp.12036. Epub 2013 Jan 7. Review. PubMed PMID: 23294014.

Sonuga-Barke E, Brandeis D, Cortese S, Daley D, Danckaerts M, Döpfner M, Ferrin M, Holtmann M, Van der Oord S; European ADHD Guidelines Group. (2013). Response to Chronis-Tuscano et al. and Arns and Strehl Am J Psychiatry. 2013 Jul;170(7):800-2. doi: 10.1176/appi.ajp.2013.13020208r. PubMed PMID: 23820834.

Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Döpfner M, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong IC, Sergeant J; European ADHD Guidelines Group. (2013). Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments Am J Psychiatry. 2013 Mar;170(3):275-89. doi: 10.1176/appi.ajp.2012.12070991. Review. PubMed PMID: 23360949.

Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E; European Guidelines Group. (2011). European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37. doi: 10.1007/s00787-010-0140-6. Epub 2010 Nov 3. PubMed PMID: 21042924; PubMed Central PMCID: PMC3012210

Sergeant JA, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Döpfner M, Rothenberger A, Santosh P, Sonuga-Barke EJ, Steinhausen HC, Taylor E, Zuddas A (2010). Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations. Eur Child Adolesc Psychiatry. 2010 Sep;19(9):737-9. doi: 10.1007/s00787-010-0114-8. Epub 2010 Jun 12. Erratum in: Eur Child Adolesc Psychiatry. 2010 Sep;19(9):743. Buitelar, Jan [corrected to Buitelaar, Jan]. PubMed PMID: 20549526; PubMed Central PMCID: PMC3128714.

Banaschewski T, EUNETHYDIS Guidelines Group (2008). [Joint position of the Guideline Group of the European Network for Hyperkintetic Disorders (EUNETHYDIS) and theGerman Central ADHD Network for ECG Recording on methylphenidate prescriptions] Z Kinder Jugendpsychiatr Psychother. 2008 Nov;36(6):437-9. doi:10.1024/1422-4917.36.6.437. German. PubMed PMID: 19034859

Sergeant J (2004). EUNETHYDIS — searching for valid aetiological candidates ofAttention-Deficit Hyperactivity Disorder or Hyperkinetic Disorder Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I43-9. PubMed PMID: 15322956.

Taylor E., Dopfner M., Sergeant J., Asherson P., Banaschewski T., Buitelaar J., et al. (2004). European clinical guidelines for hyperkinetic disorder – first upgrade. European Child & Adolescent Psychiatry, 13 Suppl 1: 7-30.

Sergeant J, Steinhausen HC (1992). European perspectives on hyperkinetic disorder Eur Child Adolesc Psychiatry. 1992 Jan;1(1):34-41. doi: 10.1007/BF02084432. PubMed PMID: 29871402.